Syngene International Limited (SYNGENE) Share Price
NSE · Healthcare · Diagnostics & Research · ISIN INE398R01022
Key metrics
- Market Cap
- ₹16,130 Cr
- P/E Ratio
- 73.53
- EPS
- 5.49
- Book Value
- 120.09
- P/B Ratio
- 3.38
- ROE
- 6.54%
- ROCE
- 10.52%
- Debt / Equity
- 0.09
- Net Margin
- 8.77%
- Revenue Growth
- 2.79%
- Profit Growth
- -36.17%
- Dividend Yield
- 0.31%
- 52W High
- ₹678.95
- 52W Low
- ₹375.25
- Market Cap Band
- mid cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Syngene International Limited
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services. It provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services. In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization. It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies. The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.
- Headquarters
- Bengaluru, India
- Employees
- 6,692
- Promoter Holding
- 52.88%
The full Syngene International Limited analysis
Create a free account to open the complete SYNGENE deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.